Rxivist logo

Delineating the molecular and phenotypic spectrum of the SETD1B-related syndrome

By Marjolein J.A. Weerts, Kristina Lanko, Francisco J. Guzman-Vega, Adam Jackson, Reshmi Ramakrishnan, Kelly J Cardona-Londono, Karla A. Pena-Guerra, Yolande van Bever, Barbara van Paassen, Anneke Kievit, Marjon van Slegtenhorst, Nicholas M. Allen, Caroline M. Kehoe, Hannah K. Robinson, Lewis Pang, Selina H. Banu, Mashaya Zaman, Stephanie Efthymiou, Henry Houlden, Irma Jarvela, Leena Lauronen, Tuomo Maatta, Isabelle Schrauwen, Suzanne M Leal, Claudia A.L. Ruivenkamp, Daniela Q.C.M Barge-Schaapveld, Cacha M.P.C.D. Peeters-Scholte, Hamid Galehdari, Neda Mazaheri, Sanjay M Sisodiya, Victoria Harrison, Angela Sun, Jenny Thies, Luis Alberto Pedroza, Yana Lara Taranchenko, Ivan K Chinn, James R. Lupski, Alexandra Garza-Flores, Jefferey McGlothlin, Lin Yang, Shaoping Huang, Xiadong Wang, Tamison Jewett, Gretchen Rosso, Xi Lin, Shehla Mohammed, J.Lawrence Merritt, Ghayda M Mirzaa, Andrew E. Timms, Joshua Scheck, Mariet Elting, Abeltje M. Polstra, Lauren Schenck, Maura R.Z. Ruzhnikov, Annalisa Vetro, Martino Montomoli, Renzo Guerrini, Daniel C Koboldt, Theresa Mihalic Mosher, Matthew T. Pastore, Kim L. McBride, Jing Peng, Zou Pan, Marjolein Willemsen, Susanne Koning, Peter D. Turnpenny, Bert B.A. de Vries, C Gilissen, Rolph Pfundt, Melissa Lees, Stephen R. Braddock, Kara C. Klemp, Fleur Vansenne, Marielle van Gijn, Catherine Quindipan, Matthew A Deardorff, J.Austin Hamm, Abbey M. Putnam, Rebecca Baud, Laurence Walsh, Sally A Lynch, Julia Baptista, Richard E. Person, Kristin G Monaghan, Amy Crunk, Jennifer Keller-Ramey, Adi Reich, Houda Zghal Elloumi, Marielle Alders, Jennifer Kerkhof, Haley McConkey, Sadegheh Haghshenas, Genomics England Research Consortium, Reza Maroofian, Bekim Sadikovic, Siddharth Banka, Stefan T Arold, Tahsin Stefan Barakat

Posted 15 Feb 2021
bioRxiv DOI: 10.1101/2021.02.11.430742

Pathogenic variants in SETD1B have been associated with a syndromic neurodevelopmental disorder including intellectual disability, language delay and seizures. To date, clinical features have been described for eleven patients with (likely) pathogenic SETD1B sequence variants. We perform an in-depth clinical characterization of a cohort of 36 unpublished individuals with SETD1B sequence variants, describing their molecular and phenotypic spectrum. Selected variants were functionally tested using in vitro and genome-wide methylation assays. Our data present evidence for a loss-of-function mechanism of SETD1B variants, resulting in a core clinical phenotype of global developmental delay, language delay including regression, intellectual disability, autism and other behavioral issues, and variable epilepsy phenotypes. Developmental delay appeared to precede seizure onset, suggesting SETD1B dysfunction impacts physiological neurodevelopment even in the absence of epileptic activity. Interestingly, males are significantly overrepresented and more severely affected, and we speculate that sex-linked traits could affect susceptibility to penetrance and the clinical spectrum of SETD1B variants. Finally, despite the possibility of non-redundant contributions of SETD1B and its paralogue SETD1A to epigenetic control, the clinical phenotypes of the related disorders share many similarities, indicating that elucidating shared and divergent downstream targets of both genes will help to understand the mechanism leading to the neurobehavioral phenotypes. Insights from this extensive cohort will facilitate the counseling regarding the molecular and phenotypic landscape of newly diagnosed patients with the SETD1B-related syndrome.

Download data

  • Downloaded 195 times
  • Download rankings, all-time:
    • Site-wide: 107,938
    • In genetics: 4,727
  • Year to date:
    • Site-wide: 10,894
  • Since beginning of last month:
    • Site-wide: 8,405

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide


Sign up for the Rxivist weekly newsletter! (Click here for more details.)